4.9/5 on Google  ·  GPhC Registered  ·  NHS & Private  ·  Same-day appointments in Kingston

The Recent Meningitis B Outbreak: What Happened and Should You Consider Vaccination?

The Recent Meningitis B Outbreak: What Happened and Should You Consider Vaccination? at The Kingston Pharmacy, Kingston upon Thames

A guide to the recent increase in awareness of meningitis B, why vaccine demand has risen, and what it means for students, parents and young adults considering vaccination.

Why Has Meningitis B Been in the News?

Meningitis B has received increased attention in recent years following reports of outbreaks, public health campaigns and growing awareness of the disease among parents and young adults. Although meningitis remains relatively uncommon, it is one of the most feared infectious diseases because of how quickly it can develop and the serious complications it can cause.


Media coverage of meningitis cases often reminds people that symptoms can progress rapidly and that the disease can affect otherwise healthy individuals. As a result, many people who were previously unaware of meningitis B vaccination have started researching whether they or their family members are protected.

What Happened During the Recent MenB Outbreak?

The recent meningococcal B outbreak in the South East of England brought renewed attention to the risks associated with meningococcal disease. Public health authorities responded with enhanced surveillance, public awareness campaigns and targeted vaccination programmes for groups considered to be at increased risk.


The outbreak highlighted an important point: while meningitis B remains uncommon, cases can still occur and clusters of infection can develop when conditions allow the bacteria to spread more easily. For many families, the outbreak served as a reminder that meningococcal disease has not disappeared and that vaccination remains an important preventative measure.

Why Did Demand for the Vaccine Increase?

Following widespread media coverage and public health messaging, many people began seeking more information about meningitis B vaccination. Parents of teenagers, university students and young adults were particularly interested in understanding whether they had previously received protection against MenB disease.


This increase in awareness led to a significant rise in demand for the Bexsero® vaccine across many parts of the UK. As more people sought vaccination appointments, some providers experienced temporary supply pressures and longer waiting times for vaccine stock. While availability has improved, the increased demand demonstrated how quickly public interest can change when awareness of a serious disease increases.

Why Are Students and Young Adults Often Mentioned?

One of the groups most frequently discussed during meningitis awareness campaigns is university students. This is because young adults are more likely to encounter situations where infections can spread through close contact — such as living in shared accommodation, attending social events and spending time in large groups.

Two key factors that affect university-age students

  • Many students entering university were born before the MenB vaccine became part of the routine childhood immunisation programme in 2015 — and may never have received protection
  • University settings involve increased social mixing and close-contact living, which can make it easier for infections to spread

This combination of increased exposure and lack of previous vaccination is one reason why MenB vaccination is commonly discussed before starting university.

What Is Bexsero®?

Bexsero® is the meningitis B vaccine used in the UK to help protect against meningococcal group B bacteria. The vaccine works by training the immune system to recognise and respond to MenB bacteria before they can cause serious illness.


Although no vaccine can provide complete protection, Bexsero® has been shown to protect against the majority of meningococcal B strains responsible for disease in the UK. For many people, vaccination provides reassurance and an additional layer of protection against a potentially serious infection.

Should You Consider MenB Vaccination?

The decision to receive MenB vaccination is a personal one and depends on individual circumstances. A healthcare professional can help determine whether vaccination may be appropriate for you. Many people choose vaccination because they:

  • Are preparing to start university
  • Live in shared accommodation
  • Were not eligible for MenB vaccination during childhood
  • Want additional protection against meningococcal disease

What to Do Next

The recent increase in awareness surrounding meningitis B has encouraged many people to learn more about the disease and the protection available through vaccination. While meningitis B remains uncommon, it can develop rapidly and have serious consequences when it occurs.


If you would like to discuss MenB vaccination or find out whether Bexsero® may be suitable for you or a family member, our team at The Kingston Pharmacy can help. Book an appointment today to receive personalised advice and discuss your vaccination options.

Ready to get started with Meningitis B Vaccine?

Complete a short consultation and our team will take care of the rest.

Start Consultation
Share the Post:

Related Posts

Join Our Newsletter